Title Credit Type Event date Cost
How Do I…? An Integrated CME Activity Designed to Assess and Compare the Clinical Decisions of Multiple Sclerosis Specialists and General... Enduring $0.00
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) --... Enduring $0.00
Conversations in Neurology: New Agents and Strategies for Migraine and Related Headache Disorders Edition (Credit Expired) Enduring $0.00
From Critique to Consensus: Quantifying & Clarifying Expert Perspectives on the Future Management of Alzheimer's Disease
    • 1.75 AMA PRA Category 1 Credit™
Enduring $0.00
Part 3: Diagnostic and Therapeutic Monitoring Strategies and their Potential Role in the Future of Disease-Modifying Therapy for Alzheimer’s Disease
    • 0.50 AMA PRA Category 1 Credit™
Enduring $0.00
Part 1: Evolving Understanding of Pathophysiology and Modern Proposed Framework of Alzheimer’s Disease
    • 0.50 AMA PRA Category 1 Credit™
Enduring $0.00
Part 2: Current Treatments and Rising Phase 3 Disease-Modifying Therapies
    • 0.75 AMA PRA Category 1 Credit™
Enduring $0.00
From Critique to Consensus: Course Evaluation Enduring $0.00
Networks in Neurology: New Agents and Strategies for Multiple Sclerosis
    • 1.75 AMA PRA Category 1 Credit™
Enduring $0.00
Networks in Neurology: New Agents and Strategies for Migraine
    • 1.25 AMA PRA Category 1 Credit™
Enduring $0.00
Needs Assessment: Assessing Knowledge And Performance Gaps Amongst Neurologists Caring For Patients with Excessive Daytime Sleepiness Secondary to... Enduring $0.00
Critical & Contested – A High-Yield Educational Series Addressing Difficult and Valuable Topics in Rare Neurologic Disorders: Neuromyelitis...
    • 0.50 AMA PRA Category 1 Credit™
Enduring $0.00
Calibrating COVID-19: The Interplay of Disease Modifying Therapy and Vaccination in Patients with Multiple Sclerosis
    • 0.50 AMA PRA Category 1 Credit™
Enduring $0.00
Wake up: Modern Strategies to Recognize and Combat Sleepiness in Narcolepsy and Idiopathic Hypersomnia - A Virtual Grand Round Series Enduring $0.00
On Target with “OFF” Therapies: An Exploration of New Agents and Strategies for Parkinson’s Disease
    • 1.00 AMA PRA Category 1 Credit™
Enduring $0.00

Pages